The global [URL=https://www.psmarketresearch.com/market-analysis/next-generation-sequencing-market]next-generation sequencing market[/URL] is growing significantly due to advances in next-generation technologies, increasing scientists and researchers’ compliance for next-generation sequencing, and low cost of next-generation sequencing methods compared to conventional sequencing methods in the industry. The unexplored next-generation sequencing market in emerging economies and increasing focus for the development of personalized medicine are creating opportunities for the global next-generation sequencing market to grow at a considerable rate in the coming years. The advanced research and development activities by the major players are propelling the demand for cost effective and efficient next-generation sequencing platforms. However, interpretation of large volume of complex sequencing data through next-generation sequencing platforms is a major challenge in global next-generation sequencing market.
Request for report sample at: [URL]https://www.psmarketresearch.com/market-analysis/next-generation-sequencing-market/report-sample[/URL]
Based on applications, the next-generation sequencing market can be categorized as diagnostics, drug discovery, animal and agriculture research, personalized medicine, and others. End-users of next-generation sequencing include academic and research institutes, biopharmaceutical and biotechnology companies, hospitals, and others. Academic and research institutes lead the global next-generation sequencing market.
Asia-Pacific is the fastest growing region in the global next-generation sequencing market. The major reasons for the fastest growth in the region are increasing healthcare expenditure, increasing genomics and proteomics related research activities and improving healthcare infrastructure. Moreover, the next-generation sequencing market is growing rapidly due to the government funding for research activities, and increasing number of academic and research institutes in emerging economies, such as India and China, of Asia-Pacific region.
Some of the major players operating in the global next-generation sequencing market are Agilent Technologies, Inc., F. Hoffmann-La Roche AG, Biomatters, Ltd., GATC Biotech AG, Illumina, Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences, Oxford Nanopore Technologies, Ltd, Macrogen, Inc. among others.